Cargando…

The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis

OBJECTIVE: This study aimed to assess (1) the prevalence of COVID-19 in patients with hip fracture; (2) the mortality rate of patients with hip fracture associated with COVID-19; (3) risk factors associated with mortality in patients with hip fracture; and (4) the effects of COVID-19 on surgical out...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Lifeng, Wei, Jingzan, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AMDA - The Society for Post-Acute and Long-Term Care Medicine. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027948/
https://www.ncbi.nlm.nih.gov/pubmed/37062371
http://dx.doi.org/10.1016/j.jamda.2023.03.011
_version_ 1784909826841640960
author Ding, Lifeng
Wei, Jingzan
Wang, Bin
author_facet Ding, Lifeng
Wei, Jingzan
Wang, Bin
author_sort Ding, Lifeng
collection PubMed
description OBJECTIVE: This study aimed to assess (1) the prevalence of COVID-19 in patients with hip fracture; (2) the mortality rate of patients with hip fracture associated with COVID-19; (3) risk factors associated with mortality in patients with hip fracture; and (4) the effects of COVID-19 on surgical outcomes of patients with hip fracture. DESIGN: Meta-analysis. SETTING AND PARTICIPANTS: Patients with hip fractures during COVID-19. METHODS: PubMed, Web of Science, and Embase were systematically reviewed. The outcomes included the prevalence of COVID-19, case fatality rate, 30-day mortality, cause of death, risk factors associated with the mortality of patients with hip fracture, time to surgery, surgical time, and length of hospitalization. Risk ratio or weight mean difference with 95% confidence intervals were used to pool the estimates. RESULTS: A total of 60 studies were included in this meta-analysis. The pooled estimate showed that the prevalence of COVID-19 was 21% in patents with hip fractures. Patients with hip fracture with COVID-19 had an increased 30-day mortality risk compared with those without the infection. The main causes of death were respiratory failure, COVID-19–associated pneumonia, multiorgan failure, and non–COVID-19 pneumonia. The hospitalization was longer in patients with COVID-19 when compared with those without the infection, but was shorter in patients during the pandemic period. The surgery time and time to surgery were not significantly different between patients during or before the pandemic period and in those with or without COVID-19. CONCLUSIONS AND IMPLICATIONS: The 30-day mortality rate was significantly higher in patients with hip fracture with COVID-19 infection than those without. Patients with COVID-19 had a higher all-cause mortality rate than those without. This information can be used by the medical community to guide the management of patients with hip fracture with COVID-19.
format Online
Article
Text
id pubmed-10027948
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AMDA - The Society for Post-Acute and Long-Term Care Medicine.
record_format MEDLINE/PubMed
spelling pubmed-100279482023-03-21 The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis Ding, Lifeng Wei, Jingzan Wang, Bin J Am Med Dir Assoc Review Article OBJECTIVE: This study aimed to assess (1) the prevalence of COVID-19 in patients with hip fracture; (2) the mortality rate of patients with hip fracture associated with COVID-19; (3) risk factors associated with mortality in patients with hip fracture; and (4) the effects of COVID-19 on surgical outcomes of patients with hip fracture. DESIGN: Meta-analysis. SETTING AND PARTICIPANTS: Patients with hip fractures during COVID-19. METHODS: PubMed, Web of Science, and Embase were systematically reviewed. The outcomes included the prevalence of COVID-19, case fatality rate, 30-day mortality, cause of death, risk factors associated with the mortality of patients with hip fracture, time to surgery, surgical time, and length of hospitalization. Risk ratio or weight mean difference with 95% confidence intervals were used to pool the estimates. RESULTS: A total of 60 studies were included in this meta-analysis. The pooled estimate showed that the prevalence of COVID-19 was 21% in patents with hip fractures. Patients with hip fracture with COVID-19 had an increased 30-day mortality risk compared with those without the infection. The main causes of death were respiratory failure, COVID-19–associated pneumonia, multiorgan failure, and non–COVID-19 pneumonia. The hospitalization was longer in patients with COVID-19 when compared with those without the infection, but was shorter in patients during the pandemic period. The surgery time and time to surgery were not significantly different between patients during or before the pandemic period and in those with or without COVID-19. CONCLUSIONS AND IMPLICATIONS: The 30-day mortality rate was significantly higher in patients with hip fracture with COVID-19 infection than those without. Patients with COVID-19 had a higher all-cause mortality rate than those without. This information can be used by the medical community to guide the management of patients with hip fracture with COVID-19. AMDA - The Society for Post-Acute and Long-Term Care Medicine. 2023-06 2023-03-21 /pmc/articles/PMC10027948/ /pubmed/37062371 http://dx.doi.org/10.1016/j.jamda.2023.03.011 Text en © 2023 AMDA - The Society for Post-Acute and Long-Term Care Medicine. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Ding, Lifeng
Wei, Jingzan
Wang, Bin
The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis
title The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis
title_full The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis
title_fullStr The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis
title_full_unstemmed The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis
title_short The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis
title_sort impact of covid-19 on the prevalence, mortality, and associated risk factors for mortality in patients with hip fractures: a meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027948/
https://www.ncbi.nlm.nih.gov/pubmed/37062371
http://dx.doi.org/10.1016/j.jamda.2023.03.011
work_keys_str_mv AT dinglifeng theimpactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis
AT weijingzan theimpactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis
AT wangbin theimpactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis
AT dinglifeng impactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis
AT weijingzan impactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis
AT wangbin impactofcovid19ontheprevalencemortalityandassociatedriskfactorsformortalityinpatientswithhipfracturesametaanalysis